Novo Nordisk Sues Florida Pharmacies Over Copycat Drugs

Novo Nordisk on Thursday accused three Florida pharmacies of illegally selling products claiming to contain semaglutide, the active ingredient in weight loss and diabetes drugs Wegovy, Ozempic, and Rybelsus.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994088?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost